Ledger.Open graph →
SEC Form D · filed November 30, 2020

PLx Pharma Inc

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SPARTA, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John W. Hadden Ii · HOUSTON, TXDirectorNatasha Giordano · Hoboken, NJExec · DirectorRita O'Connor · HOUSTON, TXExecAnthony J. Bartsh · SPARTA, NJDirectorKirk J. Calhoun · HOUSTON, TXDirectorRobert J. Casale · Houston, TXDirectorGary J. Balkema · HOUSTON, TXDirectorMichael J. Valentino · Denver, COExec · DirectorJohn W. Hadden Ii · HOUSTON, TXDirectorNatasha Giordano · HOUSTON, TXExec · DirectorRita O'Connor · HOUSTON, TXExecAnthony J. Bartsh · SPARTA, NJDirectorKirk J. Calhoun · HOUSTON, TXDirectorRobert J. Casale · Houston, TXDirectorGary J. Balkema · HOUSTON, TXDirectorMichael J. Valentino · DUBLIN, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗